Regeneron Pharmaceuticals, Inc.
Symbole: REGN
NASDAQ
883.2
USDPrix du marché aujourd'hui
23.8135
Ratio P/E
0.2678
Ratio PEG
95.34B
Cap MRK
- 0.00%
Rendement DIV
Regeneron Pharmaceuticals, Inc. Structure de gestion
Informations sur la direction
Nom de l'entreprise | Titre de l'entreprise |
---|---|
Dr. Leonard S. Schleifer M.D., Ph.D. | Co-Founder, President, Chief Executive Officer & Co-Chairman |
Dr. Andrew J. Murphy Ph.D. | Executive Vice President of Research |
Mr. Daniel P. Van Plew | Executive Vice President and GM of Industrial Operations & Product Supply |
Mr. Christopher R. Fenimore CPA | Senior Vice President of Finance & Chief Financial Officer |
Mr. Ryan Crowe | Senior Vice President of Investor Relations & Strategic Analysis |
Ms. Melissa Lozner | Senior Vice President & Chief Compliance Officer |
Dr. George D. Yancopoulos M.D., Ph.D. | Co-Founder, President, Chief Scientific Officer & Co-Chairman |
Ms. Patrice Gilooly | Senior Vice President of Quality Assurance & Operations |
Mr. Bob McCowan | Senior Vice President of IT & Chief Information Officer |
Mr. Joseph J. LaRosa | Executive Vice President, General Counsel & Secretary |
Actions similaires
Vous pouvez également être intéressé par :MRVI
Direction générale :
- Ms. Debra Hart
- Ms. Rebecca Buzzeo
- Dr. Kate E. Brode...
CMRA
Direction générale :
- Ms. Janice Marie ...
- Dr. David Soane ...
- Mr. Michael G. Ca...
T5O.DE
Direction générale :
- Dr. Mark-André F...
- Dr. Dirk Kaiser
- Dr. Bruno Rosen
HBC.OL
Direction générale :
- Dr. Crawford Lind...
- Mr. James Berger
- Ms. Angelika Flo...
PPBT
Direction générale :
- Mr. Ido Morpurgo...
- Mr. Lior Fhima C...
- Dr. Michael Schi...
SPHRF
Direction générale :
- Ms. Cheryl Maley...
- Mr. Justin Cahill